{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:45:49Z","timestamp":1791978349952,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008340","name":"Elsass Fonden","doi-asserted-by":"publisher","award":["19\/3\/0274"],"award-info":[{"award-number":["19\/3\/0274"]}],"id":[{"id":"10.13039\/501100008340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Synaptic vesicle glycoprotein-2 (SV2) is a family of proteins consisting of SV2A, SV2B, and SV2C. This protein family has attracted attention in recent years after SV2A was shown to be an epileptic drug target and a perhaps a biomarker of synaptic density. So far, the anatomical localization of these proteins in the rodent and human brain have been reported, but co-expression of SV2 genes on a cellular level, their expressions in the human brain, comparison to radioligand binding, any possible regulation in epilepsy are not known. We have here analyzed the expression of SV2 genes in neuronal subtypes in the temporal neocortex in selected specimens by using single nucleus-RNA sequencing, and performed quantitative PCR in populations of temporal lobe epilepsy (TLE) patients and healthy controls. [\n                    <jats:sup>3<\/jats:sup>\n                    H]-UCB-J autoradiography was performed to analyze the correlation between the mRNA transcript and binding capacity to SV2A. Our data showed that the SV2A transcript is expressed in all glutamatergic and GABAergic cortical subtypes, while SV2B expression is restricted to only the glutamatergic neurons and SV2C has very limited expression in a small subgroup of GABAergic interneurons. The level of [\n                    <jats:sup>3<\/jats:sup>\n                    H]-UCB-J binding and the concentration of SV2A mRNA is strongly correlated in each patient, and the expression is lower in the TLE patients. There is no relationship between SV2A expression and age, sex, seizure frequency, duration of epilepsy, or whether patients were recently treated with levetiracetam or not. Collectively, these findings point out a neuronal subtype-specific distribution of the expression of the three SV2 genes, and the lower levels of both radioligand binding and expression further emphasize the significance of these proteins in this disease.\n                  <\/jats:p>","DOI":"10.1186\/s13041-022-00931-w","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T03:13:28Z","timestamp":1652670808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE)"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4199-1974","authenticated-orcid":false,"given":"Burcu A.","family":"Pazarlar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay S.","family":"Aripaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Petukhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pinborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Khodosevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-6861","authenticated-orcid":false,"given":"Jens D.","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"931_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/S0896-6273(00)81046-6","volume":"24","author":"R Janz","year":"1999","unstructured":"Janz R, Goda Y, Geppert M, Missler M, S\u00fcdhof TC. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron. 1999;24:1003\u201316.","journal-title":"Neuron"},{"key":"931_CR2","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1021\/acschemneuro.9b00351","volume":"10","author":"KA Stout","year":"2019","unstructured":"Stout KA, Dunn AR, Hoffman C, Miller GW. The synaptic vesicle glycoprotein 2: structure, function, and disease relevance. ACS Chem Neurosci. 2019;10:3927\u201338.","journal-title":"ACS Chem Neurosci"},{"key":"931_CR3","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1111\/ejn.12360","volume":"38","author":"JG Mendoza-Torreblanca","year":"2013","unstructured":"Mendoza-Torreblanca JG, Vanoye-Carlo A, Phillips-Farf\u00e1n BV, Carmona-Aparicio L, G\u00f3mez-Lira G. Synaptic vesicle protein 2A: basic facts and role in synaptic function. Eur J Neurosci. 2013;38:3529\u201339.","journal-title":"Eur J Neurosci"},{"issue":"11","key":"931_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","volume":"30","author":"W L\u00f6scher","year":"2016","unstructured":"L\u00f6scher W, Gillard M, Sands ZA, Kaminski RM, Klitgaard H. Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond. CNS Drugs. 2016;30(11):1055\u201377.","journal-title":"CNS Drugs"},{"key":"931_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2017.00148","volume":"10","author":"O Bartholome","year":"2017","unstructured":"Bartholome O, Van Den Ackerveken P, Gil JS, de Bonardeaux Labrassinne O, Leprince P, Franzen R, et al. Puzzling out synaptic vesicle 2 family members functions. Front Mol Neurosci. 2017;10:1\u201315.","journal-title":"Front Mol Neurosci"},{"key":"931_CR6","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle is the protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci USA. 2004;101:9861\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"931_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cell.2016.09.057","volume":"167","author":"MA Rogawski","year":"2016","unstructured":"Rogawski MA. Bench to bedside a new SV2A ligand for epilepsy. Cell. 2016;167:587.","journal-title":"Cell"},{"issue":"4","key":"931_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.trci.2017.08.004","volume":"3","author":"MA Bahri","year":"2017","unstructured":"Bahri MA, Plenevaux A, Aerts J, Bastin C, Becker G, Mercier J, et al. Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H. Alzheimer\u2019s Dement Transl Res Clin Interv. 2017;3(4):481\u20136.","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"issue":"10","key":"931_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamaneurol.2018.1836","volume":"75","author":"MK Chen","year":"2018","unstructured":"Chen MK, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin SF, et al. Assessing synaptic density in Alzheimer disease with synaptic vesicle glycoprotein 2A positron emission tomographic imaging. JAMA Neurol. 2018;75(10):1215\u201324.","journal-title":"JAMA Neurol"},{"key":"931_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules24091705","volume":"24","author":"ME Serrano","year":"2019","unstructured":"Serrano ME, Becker G, Bahri MA, Seret A, Mestdagh N, Mercier J, et al. Evaluating the in vivo specificity of [18F]UCB-H for the SV2A protein, compared with SV2B and SV2C in rats using microPET. Molecules. 2019;24:1\u201312.","journal-title":"Molecules"},{"issue":"3","key":"931_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.25682","volume":"87","author":"D Matuskey","year":"2020","unstructured":"Matuskey D, Tinaz S, Wilcox KC, Naganawa M, Toyonaga T, Dias M, et al. Synaptic changes in Parkinson disease assessed with in vivo imaging. Ann Neurol. 2020;87(3):329\u201338.","journal-title":"Ann Neurol"},{"issue":"1","key":"931_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","volume":"10","author":"SE Holmes","year":"2019","unstructured":"Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, et al. Lower synaptic density is associated with depression severity and network alterations. Nat Commun. 2019;10(1):1529.","journal-title":"Nat Commun"},{"issue":"1","key":"931_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41467-019-14122-0","volume":"11","author":"EC Onwordi","year":"2020","unstructured":"Onwordi EC, Halff EF, Whitehurst T, Mansur A, Cotel MC, Wells L, et al. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun. 2020;11(1):246.","journal-title":"Nat Commun"},{"issue":"10","key":"931_CR14","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1111\/epi.16653","volume":"61","author":"SJ Finnema","year":"2020","unstructured":"Finnema SJ, Toyonaga T, Detyniecki K, Chen M, Dias M, Wang Q, et al. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: a [11 C]UCB-J positron emission tomography study. Epilepsia. 2020;61(10):2183\u201393.","journal-title":"Epilepsia"},{"key":"931_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0306-4522(99)00370-X","volume":"94","author":"R Janz","year":"1999","unstructured":"Janz R, S\u00fcdhof TC. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience. 1999;94:1279\u201390.","journal-title":"Neuroscience"},{"key":"931_CR16","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","volume":"14","author":"SM Bajjalieh","year":"1994","unstructured":"Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci. 1994;14:5223\u201335.","journal-title":"J Neurosci"},{"key":"931_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.brainres.2010.09.063","volume":"1367","author":"D Dardou","year":"2011","unstructured":"Dardou D, Dassesse D, Cuvelier L, Deprez T, De Ryck M, Schiffmann SN. Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system. Brain Res. 2011;1367:130\u201345.","journal-title":"Brain Res"},{"key":"931_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2017.12.029","volume":"1702","author":"AR Dunn","year":"2019","unstructured":"Dunn AR, Hoffman CA, Stout KA, Ozawa M, Dhamsania RK, Miller GW. Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain. Brain Res. 2019;1702:85\u201395.","journal-title":"Brain Res"},{"key":"931_CR19","doi-asserted-by":"publisher","first-page":"E2253","DOI":"10.1073\/pnas.1616892114","volume":"114","author":"AR Dunn","year":"2017","unstructured":"Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, et al. Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proc Natl Acad Sci USA. 2017;114:E2253\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7483","key":"931_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature12983","volume":"505","author":"A Kepecs","year":"2014","unstructured":"Kepecs A, Fishell G. Interneuron cell types are fit to function. Nature. 2014;505(7483):318\u201326.","journal-title":"Nature"},{"issue":"3","key":"931_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrn2286","volume":"9","author":"N Spruston","year":"2008","unstructured":"Spruston N. Pyramidal neurons: dendritic structure and synaptic integration. Nat Rev Neurosci. 2008;9(3):206\u201321.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"931_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/neuro.01.026.2008","volume":"2","author":"A Burkhalter","year":"2008","unstructured":"Burkhalter A. Many specialists for suppressing cortical excitation. Front Neurosci. 2008;2(2):155\u201367.","journal-title":"Front Neurosci"},{"key":"931_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1528-1167.2008.01727.x","volume":"50","author":"EA Van Vliet","year":"2009","unstructured":"Van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia. 2009;50:422\u201333.","journal-title":"Epilepsia"},{"key":"931_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12031-009-9288-2","volume":"39","author":"G Feng","year":"2009","unstructured":"Feng G, Xiao F, Lu Y, Huang Z, Yuan J, Xiao Z, et al. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. J Mol Neurosci. 2009;39:354\u20139.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"931_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/nan.12054","volume":"40","author":"J Cr\u00e8vec\u0153ur","year":"2014","unstructured":"Cr\u00e8vec\u0153ur J, Kaminski RM, Rogister B, Foerch P, Vandenplas C, Neveux M, et al. Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis. Neuropathol Appl Neurobiol. 2014;40(2):191\u2013204.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"348","key":"931_CR26","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin S-F, Chen M-K, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8(348):348ra96.","journal-title":"Sci Transl Med"},{"issue":"1","key":"931_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"U Pfisterer","year":"2020","unstructured":"Pfisterer U, Petukhov V, Demharter S, Meichsner J, Thompson JJ, Batiuk MY, et al. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis. Nat Commun. 2020;11(1):1\u20139.","journal-title":"Nat Commun"},{"key":"931_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1523\/JNEUROSCI.4074-09.2010","volume":"30","author":"M Gr\u00f8nborg","year":"2010","unstructured":"Gr\u00f8nborg M, Pavlos NJ, Brunk I, Chua JJE, M\u00fcnster-Wandowski A, Riedel D, et al. Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. J Neurosci. 2010;30:2\u201312.","journal-title":"J Neurosci"},{"key":"931_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2011.00032","volume":"5","author":"L Bragina","year":"2012","unstructured":"Bragina L, Fattorini G, Giovedi S, Melone M, Bosco F, Benfenati F, et al. Analysis of synaptotagmin, SV2, and Rab3 expression in cortical glutamatergic and GABAergic axon terminals. Front Cell Neurosci. 2012;5:1\u20139.","journal-title":"Front Cell Neurosci"},{"key":"931_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brainres.2013.02.041","volume":"1507","author":"D Dardou","year":"2013","unstructured":"Dardou D, Monlezun S, Foerch P, Courade JP, Cuvelier L, De Ryck M, et al. A role for Sv2c in basal ganglia functions. Brain Res. 2013;1507:61\u201373.","journal-title":"Brain Res"},{"key":"931_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuroscience.2019.09.004","volume":"419","author":"JG Mendoza-Torreblanca","year":"2019","unstructured":"Mendoza-Torreblanca JG, Garc\u00eda-Cruz ME, S\u00e1nchez-Cruz I, Gomez-Gonzalez B, Ju\u00e1rez-M\u00e9ndez S, G\u00f3mez-Lira G. Analysis of differential expression of synaptic vesicle protein 2A in the adult rat brain. Neuroscience. 2019;419:108\u201320.","journal-title":"Neuroscience"},{"issue":"10","key":"931_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/syn.22157","volume":"74","author":"K Varn\u00e4s","year":"2020","unstructured":"Varn\u00e4s K, Stepanov V, Halldin C. Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain. Synapse. 2020;74(10): e22157.","journal-title":"Synapse"},{"key":"931_CR33","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1528-1167.2008.01955.x","volume":"50","author":"ST Toering","year":"2009","unstructured":"Toering ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WGM, et al. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia. 2009;50:1409\u201318.","journal-title":"Epilepsia"},{"issue":"2","key":"931_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuron.2018.10.009","volume":"100","author":"L Lim","year":"2018","unstructured":"Lim L, Mi D, Llorca A, Mar\u00edn O. Development and functional diversification of cortical interneurons. Neuron. 2018;100(2):294\u2013313.","journal-title":"Neuron"},{"key":"931_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neures.2014.07.002","volume":"86","author":"T Kumamoto","year":"2014","unstructured":"Kumamoto T, Hanashima C. Neuronal subtype specification in establishing mammalian neocortical circuits. Neurosci Res. 2014;86:37\u201349.","journal-title":"Neurosci Res"},{"key":"931_CR36","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.aaa1934","volume":"347","author":"A Zeisel","year":"2015","unstructured":"Zeisel A, Mu\u00f1oz-Manchado AB, Codeluppi S, L\u00f6nnerberg P, La Manno G, Jur\u00e9us A, et al. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science. 2015;347:1138\u201342.","journal-title":"Science"},{"key":"931_CR37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2018.07.028","volume":"174","author":"A Saunders","year":"2018","unstructured":"Saunders A, Macosko EZ, Wysoker A, Goldman M, Krienen FM, de Rivera H, et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell. 2018;174:1015-1030.e16.","journal-title":"Cell"},{"issue":"11","key":"931_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001207","volume":"6","author":"FL Yeh","year":"2010","unstructured":"Yeh FL, Dong M, Yao J, Tepp WH, Lin G, Johnson EA, et al. SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog. 2010;6(11): e1001207.","journal-title":"PLoS Pathog"},{"key":"931_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep23176","volume":"6","author":"N Dehghani","year":"2016","unstructured":"Dehghani N, Peyrache A, Telenczuk B, Le Van QM, Halgren E, Cash SS, et al. Dynamic balance of excitation and inhibition in human and monkey neocortex. Sci Rep. 2016;6:1\u201312.","journal-title":"Sci Rep"},{"issue":"10","key":"931_CR40","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.tins.2018.07.015","volume":"41","author":"JA Cardin","year":"2018","unstructured":"Cardin JA. Inhibitory interneurons regulate temporal precision and correlations in cortical circuits. Trends Neurosci. 2018;41(10):689\u2013700.","journal-title":"Trends Neurosci"},{"key":"931_CR41","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1126\/science.aag2599","volume":"355","author":"W Mu\u00f1oz","year":"2017","unstructured":"Mu\u00f1oz W, Tremblay R, Levenstein D, Rudy B. Layer-specific modulation of neocortical dendritic inhibition during active wakefulness. Science. 2017;355:954\u20139.","journal-title":"Science"},{"key":"931_CR42","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/nn.3544","volume":"16","author":"S Lee","year":"2013","unstructured":"Lee S, Kruglikov I, Huang ZJ, Fishell G, Rudy B. A disinhibitory circuit mediates motor integration in the somatosensory cortex. Nat Neurosci. 2013;16:1662\u201370.","journal-title":"Nat Neurosci"},{"issue":"2","key":"931_CR43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/hbm.25231","volume":"42","author":"R Li","year":"2021","unstructured":"Li R, Wang H, Wang L, Zhang L, Zou T, Wang X, et al. Shared and distinct global signal topography disturbances in subcortical and cortical networks in human epilepsy. Hum Brain Mapp. 2021;42(2):412\u201326.","journal-title":"Hum Brain Mapp"},{"key":"931_CR44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/neuonc\/nop028","volume":"12","author":"M De Groot","year":"2010","unstructured":"De Groot M, Toering ST, Boer K, Spliet WGM, Heimans JJ, Aronica E, et al. Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex. Neuro Oncol. 2010;12:265\u201373.","journal-title":"Neuro Oncol"},{"issue":"232","key":"931_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.117877","volume":"15","author":"L Michiels","year":"2021","unstructured":"Michiels L, Delva A, van Aalst J, Ceccarini J, Vandenberghe W, Vandenbulcke M, et al. Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study. Neuroimage. 2021;15(232): 117877.","journal-title":"Neuroimage"},{"key":"931_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-14-87","volume":"14","author":"J Cr\u00e8vec\u0153ur","year":"2013","unstructured":"Cr\u00e8vec\u0153ur J, Foerch P, Doupagne M, Thielen C, Vandenplas C, Moonen G, et al. Expression of SV2 isoforms during rodent brain development. BMC Neurosci. 2013;14:1\u201310.","journal-title":"BMC Neurosci"},{"key":"931_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.brainres.2019.03.021","volume":"1715","author":"A Vanoye-Carlo","year":"2019","unstructured":"Vanoye-Carlo A, G\u00f3mez-Lira G. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development. Brain Res. 2019;1715:73\u201383.","journal-title":"Brain Res"},{"key":"931_CR48","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.2967\/jnumed.118.223867","volume":"60","author":"T Toyonaga","year":"2019","unstructured":"Toyonaga T, Smith LM, Finnema SJ, Gallezot JD, Naganawa M, Bini J, et al. In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib in a mouse model of Alzheimer disease. J Nucl Med. 2019;60:1780\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"931_CR49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.braindev.2019.07.006","volume":"42","author":"K Kobayashi","year":"2020","unstructured":"Kobayashi K, Endoh F, Ohmori I, Akiyama T. Action of antiepileptic drugs on neurons. Brain Dev. 2020;42(1):2\u20135.","journal-title":"Brain Dev"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-022-00931-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-022-00931-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-022-00931-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T09:09:02Z","timestamp":1668330542000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-022-00931-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1186\/s13041-022-00931-w","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"5 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee in the Capital Region of Denmark (H-2-2011-104) and written informed consent was obtained from all patients before surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All coauthors have reviewed and approved the contents of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}